- Taro Pharmaceuticals recalls epilepsy drug
Taro Pharmaceuticals, a Hawthorne, N.Y.-based drugmaker, is recalling one lot of its drugs, Lamotrigine, designed to treat epilepsy and bipolar disorder, after discovering it was cross-contaminated with a small amount of another drug substance. - Mavidon updates recall of skin prep lotion after bacterial contamination found
Mavidon is updating a worldwide recall of its skin-prepping lotions to include all lots of the products after discovering a bacterial contamination that could cause life-threatening infections. - Mylan recalls ulcer treatment after carcinogen found
Mylan is recalling three lots of its ulcer treatment after detecting trace amounts of a carcinogen in the product. - Aurobindo Pharma recalls antidepressant with mislabeled dosage
Generic drugmaker Aurobindo Pharma USA is recalling its antidepressant drug Mirtazapine because of a labeling error.
More articles on pharmacy:
Roche pulled a $1.5B fast one on US, whistleblower physician alleges
CVS adds 15 HealthHUBs to Houston area
Nationwide Children’s to build gene therapy biofactory, create more than 100 jobs
